Nagourney Cancer Institute

Real results. Real hope.

You deserve the right cancer treatment, every time.

Your cancer is as unique as your fingerprint.  Drugs that work for one patient may not work for another, even if they carry exactly the same diagnosis.


We offer testing that measures how your cancer cells will respond to drugs BEFORE you receive them.  This testing helps select the most effective and least toxic drug regimen for your cancer.  

bouncing down arrow

Pioneer in Cancer Research Offers Powerful Testing for Cancer Treatment Selection

Dr. Robert Nagourney is an internationally recognized pioneer in cancer research and personalized cancer treatment.

He is the founder and medical director of Nagourney Cancer Institute (formerly Rational Therapeutics), Clinical Professor at the University of California, Irvine School of Medicine, and author of the book, Outliving Cancer.  

Over the past 20+ years, Dr. Nagourney and his team here at the Nagourney Cancer Institute have developed a laboratory technique, functional profiling, that measures how cancer cells respond when they are exposed to a wide variety of drugs and drug combinations.  

Put simply, functional profiling is a real-time measure of which drugs cause your cancer cells to die, through a process called programmed cell death.  By using this approach, we try to determine in the laboratory the best drugs for each patient before they receive them.

This helps us select the most effective and least toxic drug regimen for your cancer.

Call us at 800-542-4357 to discuss your particular situation.

Dr. Robert Nagourney

Dr. Nagourney Featured on TEDx Talk

Among his research accomplishments, Dr. Nagourney is recognized for his work in the introduction of Cisplatin/Gemcitabine doublets (two drugs given together) in the treatment of advanced ovarian and breast cancers.

Watch as Dr. Nagourney shares his unique insight into cancer, cancer research, and his treatment philosophy in this engaging TEDx Talk. 

The Science

Functional Profiling is the Key

With functional profiling , we can help discover the most effective and least toxic drug regimen for you PRIOR to initiating treatment.

To find the most effective treatment for you, living tumor cells are collected during biopsy or surgery.

We expose your living cancer cells in the laboratory to chemotherapy drugs, targeted agents and various combinations.

By using combinations of drugs found most effective in the laboratory, Dr. Nagourney and his team have been able to double response rates and improve survival for his patients.

We can test most types of cancers, solid and hematologic (blood).

Samples are sent to us from all over the US and internationally.  Since the test involves living cancer cells, the samples MUST arrive in a very timely manner, within 24-36 hours.

Results are generally available within 7 days of receipt of your cancer sample in our laboratory.

For more information or to order a specimen transportation kit, please call us at 800-542-4357.  It's important to call us BEFORE your biopsy or surgery.


Understanding Your Cancer

Choose from the list below to learn more about a specific type of cancer, treatment options and other useful information.
Patient Stories

Patient Stories

Read stories from actual patients and learn about their experience with cancer, getting tested, and their success in overcoming their particular disease.

Dr. Nagourney's Latest Blog Articles

In Sarcoma, Does The Absence Of Mutations Mean There Is No Cancer?

I was recently approached by the father of a young patient with recurrent sarcoma.

After several surgeries and multiple courses of chemotherapy, the...

In Cancer Medicine, the Most Dangerous People Are Often the "Experts"

Many people may be aware of the controversies surrounding micro-nutrition, diet and lifestyle, vitamin supplementation and other "holistic"...

Choosing Therapy For Stage 4 Pancreatic Cancer: What Are The Criteria?

Pancreatic cancer afflicts 53,000 patients each year in the U.S. and has overtaken breast cancer as the third leading cause of cancer death in the...